Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Journal article

OGBE A. and EWER K., (2022), JCI insight

Durability of ChAdOx1 nCov-19 vaccination in people living with HIV.

Journal article

Ogbe A. et al, (2022), JCI Insight

AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein-specific Th1 response with a diverse TCR repertoire.

Journal article

Swanson PA. et al, (2021), Science translational medicine, eabj7211 - eabj7211

Tolerability and Immunogenicity After a Late Second Dose or a Third Dose of ChAdOx1 nCoV-19 (AZD1222)

Journal article

Flaxman A. et al, (2021), SSRN Electronic Journal